Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hassan Khamgan"'
Autor:
Salem Baldi, Yun He, Igor Ivanov, Hassan Khamgan, Mohammed Safi, Mohammed Alradhi, Abdullah Shopit, Abdullah Al-Danakh, Murad Al-Nusaif, Yaping Gao, Hui Tian
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background and Objective: Understanding the tumor microenvironment (TME) and immune cell infiltration (ICI) may help guide immunotherapy efforts for colon cancer (COAD). However, whether ARID1B is truly regulated by hypermethylation or linked to immu
Externí odkaz:
https://doaj.org/article/e460313b43df46ceae42470d45d17bfc
Autor:
Salem Baldi, Hassan Khamgan, Yuanyuan Qian, Han Wu, Zhenyu Zhang, Mengyan Zhang, Yina Gao, Mohammed Safi, Mohammed Al-Radhi, Yun-Fei Zuo
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
AT-rich interaction domain 1A (ARID1A) is a tumor suppressor gene that mutates in several cancer types, including breast cancer, ovarian cancer, and colorectal cancer (CRC). In colon adenocarcinoma (COAD), the low expression of ARID1A was reported bu
Externí odkaz:
https://doaj.org/article/df1e54adeb994011ab113c37d3ccf552
Autor:
Salem Baldi, Qianshi Zhang, Zhenyu Zhang, Mohammed Safi, Hassan Khamgan, Han Wu, Mengyan Zhang, Yuanyuan Qian, Yina Gao, Abdullah Shopit, Abdullah Al‐Danakh, Mohammed Alradhi, Murad Al‐Nusaif, Yunfei Zuo
Publikováno v:
Journal of cellular and molecular medicine. 26(24)
According to our prior findings, ARID1A expression is decreased in colon cancer, which has a poor prognosis. In this study, we investigated the ARID1A-VIM/CDH1 signalling axis's role in colon cancer proliferation and migration. The differentially exp
Autor:
Mohammed Alradhi, Han Wu, Yuanyuan Qian, Zhenyu Zhang, Mohammed Safi, Hassan Khamgan, Yina Gao, Mengyan Zhang, Yun-Fei Zuo, Salem Baldi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
AT-rich interaction domain 1A (ARID1A) is a tumor suppressor gene that mutates in several cancer types, including breast cancer, ovarian cancer, and colorectal cancer (CRC). In colon adenocarcinoma (COAD), the low expression of ARID1A was reported bu